cbdMD, Inc. (YCBD)
NYSE American
Key stats Fiscal year 2025
Income statement
- Revenue
- 19,190,468 -1.5%
- Net income
- -2,040,902
- Gross profit
- 11,968,255
- Operating income
- -2,162,590
- Earnings per share
- -1.09
Growth and profitability
- Gross margin
- 62.37
- Operating margin
- -11.27
- Net margin
- -10.63
- Return on equity
- -28.24
- Return on assets
- -19.59
- Free cash flow margin
- -8.53
Balance sheet
- Total assets
- 10,419,950
- Total liabilities
- 3,193,843
- Shareholders' equity
- 7,226,107
- Cash and equivalents
- 2,261,242
- Current ratio
- 2.05
Cash flow and ratios
- Operating cash flow
- -1,452,375
- Free cash flow
- -1,636,547
Shareholder returns
- Shares outstanding
- 11,205,045
- Book value per share
- 0.64
Company information
- Headquarters
- Charlotte, NC
- Exchange
- NYSE American
- Fiscal year end
- 09-30
- Industry (SEC)
- Perfumes, Cosmetics & Other Toilet Preparations
Fiscal year end: · Source: SEC EDGAR
cbdMD, Inc. trades on NYSE American under the ticker symbol YCBD. This page brings together its price chart, company profile, key financial figures and technical indicators.